Search

Gigi Georgiana Huang

Examiner (ID: 12753)

Most Active Art Unit
1613
Art Unit(s)
1618, 1627, 1629, 1609, 1612, 1613, 1617, 1621
Total Applications
781
Issued Applications
217
Pending Applications
66
Abandoned Applications
506

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6234981 [patent_doc_number] => 20100266685 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'Seamless Coated Spherical Filled Capsules' [patent_app_type] => utility [patent_app_number] => 12/063497 [patent_app_country] => US [patent_app_date] => 2005-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10203 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20100266685.pdf [firstpage_image] =>[orig_patent_app_number] => 12063497 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/063497
Seamless Coated Spherical Filled Capsules Aug 15, 2005 Abandoned
Array ( [id] => 5649772 [patent_doc_number] => 20060135507 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-22 [patent_title] => 'Therapeutic agent for overactive bladder involved in aging' [patent_app_type] => utility [patent_app_number] => 11/203899 [patent_app_country] => US [patent_app_date] => 2005-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 12339 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20060135507.pdf [firstpage_image] =>[orig_patent_app_number] => 11203899 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/203899
Therapeutic agent for overactive bladder involved in aging Aug 14, 2005 Abandoned
Array ( [id] => 5743686 [patent_doc_number] => 20060089411 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-27 [patent_title] => 'Treatment of Stargardt\'s disease and other lipofuscin disorders with combined retinaldehyde inhibitor and zeaxanthin' [patent_app_type] => utility [patent_app_number] => 11/198114 [patent_app_country] => US [patent_app_date] => 2005-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 17353 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0089/20060089411.pdf [firstpage_image] =>[orig_patent_app_number] => 11198114 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/198114
Treatment of Stargardt's disease and other lipofuscin disorders with combined retinaldehyde inhibitor and zeaxanthin Aug 5, 2005 Abandoned
Array ( [id] => 5672076 [patent_doc_number] => 20060177430 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-10 [patent_title] => 'Treatment of ocular disorders with ophthalmic formulations containing methylsulfonylmethane as a transport enhancer' [patent_app_type] => utility [patent_app_number] => 11/183479 [patent_app_country] => US [patent_app_date] => 2005-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 21200 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20060177430.pdf [firstpage_image] =>[orig_patent_app_number] => 11183479 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/183479
Treatment of ocular disorders with ophthalmic formulations containing methylsulfonylmethane as a transport enhancer Jul 14, 2005 Abandoned
Array ( [id] => 5739107 [patent_doc_number] => 20060009498 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-12 [patent_title] => 'Ophthalmic compositions and methods for treating ophthalmic conditions' [patent_app_type] => utility [patent_app_number] => 11/180752 [patent_app_country] => US [patent_app_date] => 2005-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5619 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20060009498.pdf [firstpage_image] =>[orig_patent_app_number] => 11180752 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/180752
Ophthalmic compositions and methods for treating ophthalmic conditions Jul 10, 2005 Abandoned
Array ( [id] => 5739131 [patent_doc_number] => 20060009522 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-12 [patent_title] => 'Compositions and methods for treating eye disorders and conditions' [patent_app_type] => utility [patent_app_number] => 11/171815 [patent_app_country] => US [patent_app_date] => 2005-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11014 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20060009522.pdf [firstpage_image] =>[orig_patent_app_number] => 11171815 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/171815
Compositions and methods for treating eye disorders and conditions Jun 29, 2005 Abandoned
Array ( [id] => 5895457 [patent_doc_number] => 20060003996 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-05 [patent_title] => 'Intralesional treatment of psoriasis' [patent_app_type] => utility [patent_app_number] => 11/155450 [patent_app_country] => US [patent_app_date] => 2005-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5375 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20060003996.pdf [firstpage_image] =>[orig_patent_app_number] => 11155450 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/155450
Intralesional treatment of psoriasis Jun 16, 2005 Abandoned
Array ( [id] => 4570901 [patent_doc_number] => 07824697 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-02 [patent_title] => 'High concentration baclofen preparations' [patent_app_type] => utility [patent_app_number] => 11/156370 [patent_app_country] => US [patent_app_date] => 2005-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7062 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/824/07824697.pdf [firstpage_image] =>[orig_patent_app_number] => 11156370 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/156370
High concentration baclofen preparations Jun 16, 2005 Issued
Array ( [id] => 5277898 [patent_doc_number] => 20090130030 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-21 [patent_title] => 'Plural Activating Optical Change Toothpastes, Stimuli and Elements' [patent_app_type] => utility [patent_app_number] => 11/629113 [patent_app_country] => US [patent_app_date] => 2005-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7837 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20090130030.pdf [firstpage_image] =>[orig_patent_app_number] => 11629113 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/629113
Plural Activating Optical Change Toothpastes, Stimuli and Elements Jun 9, 2005 Abandoned
Array ( [id] => 5064086 [patent_doc_number] => 20070225727 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-27 [patent_title] => 'Transparent Tissue-Visualizng Preparation' [patent_app_type] => utility [patent_app_number] => 11/597976 [patent_app_country] => US [patent_app_date] => 2005-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9821 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0225/20070225727.pdf [firstpage_image] =>[orig_patent_app_number] => 11597976 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/597976
Transparent Tissue-Visualizng Preparation May 29, 2005 Abandoned
Array ( [id] => 5182618 [patent_doc_number] => 20070053964 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-08 [patent_title] => 'Ophthalmic percutaneously absorbed preparation containing muscarinic receptor agonist' [patent_app_type] => utility [patent_app_number] => 10/569772 [patent_app_country] => US [patent_app_date] => 2005-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8455 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 33 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20070053964.pdf [firstpage_image] =>[orig_patent_app_number] => 10569772 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/569772
Ophthalmic percutaneously absorbed preparation containing muscarinic receptor agonist May 19, 2005 Abandoned
Array ( [id] => 5590503 [patent_doc_number] => 20060039954 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-23 [patent_title] => 'Ocular formulations with neuroprotectants to reduce Alzheimer and neurotoxic risks created by large zinc dosages' [patent_app_type] => utility [patent_app_number] => 11/133125 [patent_app_country] => US [patent_app_date] => 2005-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 37426 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20060039954.pdf [firstpage_image] =>[orig_patent_app_number] => 11133125 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/133125
Ocular formulations with neuroprotectants to reduce Alzheimer and neurotoxic risks created by large zinc dosages May 17, 2005 Abandoned
Array ( [id] => 7046161 [patent_doc_number] => 20050250756 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-10 [patent_title] => 'Use of targeted oxidative therapeutic formulation in treatment of age-related macular degeneration' [patent_app_type] => utility [patent_app_number] => 11/125932 [patent_app_country] => US [patent_app_date] => 2005-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5604 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0250/20050250756.pdf [firstpage_image] =>[orig_patent_app_number] => 11125932 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/125932
Use of targeted oxidative therapeutic formulation in treatment of age-related macular degeneration May 9, 2005 Abandoned
Array ( [id] => 7045226 [patent_doc_number] => 20050249821 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-10 [patent_title] => 'Nutritional supplement for treatment of ocular diseases' [patent_app_type] => utility [patent_app_number] => 11/122481 [patent_app_country] => US [patent_app_date] => 2005-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5031 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20050249821.pdf [firstpage_image] =>[orig_patent_app_number] => 11122481 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/122481
Nutritional supplement for treatment of ocular diseases May 4, 2005 Issued
Array ( [id] => 5835489 [patent_doc_number] => 20060247321 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-02 [patent_title] => 'Abnormal Cannabidiols as agents useful in combination therapy for lowering intraocular pressure' [patent_app_type] => utility [patent_app_number] => 11/121528 [patent_app_country] => US [patent_app_date] => 2005-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2237 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20060247321.pdf [firstpage_image] =>[orig_patent_app_number] => 11121528 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/121528
Abnormal Cannabidiols as agents useful in combination therapy for lowering intraocular pressure May 1, 2005 Abandoned
Array ( [id] => 7244106 [patent_doc_number] => 20050271705 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-08 [patent_title] => 'Retinoid-containing sustained release intraocular drug delivery system and related methods' [patent_app_type] => utility [patent_app_number] => 11/119024 [patent_app_country] => US [patent_app_date] => 2005-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 50 [patent_figures_cnt] => 50 [patent_no_of_words] => 27534 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0271/20050271705.pdf [firstpage_image] =>[orig_patent_app_number] => 11119024 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/119024
Retinoid-containing sustained release intraocular drug delivery system and related methods Apr 28, 2005 Abandoned
Array ( [id] => 7069093 [patent_doc_number] => 20050244476 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-03 [patent_title] => 'Intraocular implants and methods for improving vision' [patent_app_type] => utility [patent_app_number] => 11/119021 [patent_app_country] => US [patent_app_date] => 2005-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 17809 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0244/20050244476.pdf [firstpage_image] =>[orig_patent_app_number] => 11119021 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/119021
Intraocular implants and methods for improving vision Apr 28, 2005 Issued
Array ( [id] => 5835434 [patent_doc_number] => 20060247265 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-02 [patent_title] => 'Therapies for treating disorders of the eye' [patent_app_type] => utility [patent_app_number] => 11/116942 [patent_app_country] => US [patent_app_date] => 2005-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3550 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20060247265.pdf [firstpage_image] =>[orig_patent_app_number] => 11116942 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/116942
Therapies for treating disorders of the eye Apr 27, 2005 Abandoned
Array ( [id] => 5771636 [patent_doc_number] => 20050267087 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-01 [patent_title] => 'Inflammatory eye disease' [patent_app_type] => utility [patent_app_number] => 11/115687 [patent_app_country] => US [patent_app_date] => 2005-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7380 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20050267087.pdf [firstpage_image] =>[orig_patent_app_number] => 11115687 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/115687
Inflammatory eye disease Apr 26, 2005 Abandoned
Array ( [id] => 4977909 [patent_doc_number] => 20070219142 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-20 [patent_title] => 'Composition Comprising a Diuretic and/or Cardiac Glycosed for the Treatment of Dna Viral Infections of the Eye' [patent_app_type] => utility [patent_app_number] => 11/568144 [patent_app_country] => US [patent_app_date] => 2005-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3584 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0219/20070219142.pdf [firstpage_image] =>[orig_patent_app_number] => 11568144 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/568144
Composition Comprising a Diuretic and/or Cardiac Glycosed for the Treatment of Dna Viral Infections of the Eye Apr 24, 2005 Abandoned
Menu